Invivyd (IVVD) | Stock Overview & Key Data
Invivyd Performance Comparison
Stock Range
Today's Range
Low: $0.96
High: $1.19
on September 5, 2025
52 Week Range
Low: $0.35
High: $2.74
on January 31, 2025
on February 6, 2025
All-Time High: $78.82 on November 29, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$238.7M
EPS
-0.92
P/E Ratio (TTM)
-0.80
Forward P/E
-5.70
P/B Ratio
3.20
PEG Ratio
0.01
Div. Yield
N/A
ROE
-120.08%
Beta
0.552
Debt to Equity
6.93
Financial Highlights
Profitability
Gross Margin
94.19%
Operating Margin
-127.78%
Profit Margin
-238.33%
Returns and Earnings
Return on Assets (TTM)
-53.25%
Return on Equity (TTM)
-120.08%
EBITDA
$-111.8M
Net Income (TTM)
$-110.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$0.39
Quarterly Revenue Growth (YoY)
420.60%
Quarterly Earnings Growth (YoY)
420.58%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Invivyd IVVD | 238.69M Micro-cap | 17.53% | 58.33% | 22.58% | 7.55% | 137.50% | 40.74% | -75.22% | -94.54% |
| Vertex VRTX | 101.56B Large-cap | 1.30% | 5.64% | -10.75% | -19.43% | -2.38% | -15.36% | 35.61% | 53.56% |
| Regeneron REGN | 60.77B Large-cap | -1.26% | 0.61% | 18.70% | -16.56% | -19.83% | -49.33% | -20.84% | 5.26% |
| Third Harmonic Bio THRD | 242.79M Micro-cap | 0.00% | -1.28% | 4.47% | 56.85% | -51.27% | -53.82% | -70.11% | -70.11% |
| Tonix TNXP | 241.91M Micro-cap | -10.43% | -44.36% | -30.90% | 142.15% | -15.48% | 76.93% | 76.93% | 76.93% |
| Annexon ANNX | 238.45M Micro-cap | 5.34% | -12.50% | -14.90% | -21.38% | -60.55% | -62.26% | -66.36% | -91.25% |
Ownership & Short Interest
Insider Ownership
19.20%
Institutional Ownership
49.16%
Shares Short
3M
Short Ratio
4.10
Short % of Shares Outstanding
4.28%
Average 10-Day Volume
26M
Average 90-Day Volume
9M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is IVVD's 52-week high and low?
- In the last 52 weeks, Invivyd reached a high of $2.74 (on February 6, 2025) and a low of $0.35 (on January 31, 2025).
- What is the market cap and P/E ratio for IVVD?
- Curious about Invivyd's size and valuation? Its market capitalization stands at 238.69M. When it comes to valuation, the P/E ratio (trailing twelve months) is -0.80, and the forward P/E (looking ahead) is -5.70.
- Does IVVD pay dividends? If so, what's the yield?
- As for dividends, Invivyd isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Invivyd's main competitors or similar companies to consider before investing?
When looking at Invivyd, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Vertex
VRTX101.56B Healthcare Biotechnology -15.36% 35.61% Regeneron
REGN60.77B Healthcare Biotechnology -49.33% -20.84% Third Harmonic Bio
THRD242.79M Healthcare Biotechnology -53.82% -70.11% Tonix
TNXP241.91M Healthcare Biotechnology 76.93% 76.93% Annexon
ANNX238.45M Healthcare Biotechnology -62.26% -66.36% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Invivyd Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Invivyd's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -120.08%, the Debt to Equity ratio from the most recent quarter is 6.93, and its Gross Profit Margin stands at 94.19%.
- What is the recent revenue and earnings growth for IVVD?
- Looking at Invivyd's growth, its revenue over the trailing twelve months (TTM) was $46M. Compared to the same quarter last year (YoY), quarterly revenue grew by 420.60%, and quarterly earnings saw a YoY growth of 420.58%.
- How much of IVVD stock is held by insiders and institutions?
- Wondering who owns Invivyd stock? Company insiders (like executives and directors) hold about 19.20% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 49.16%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.